National Survey of Research Commercialisation - Australian ...
National Survey of Research Commercialisation - Australian ...
National Survey of Research Commercialisation - Australian ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 11: Licences executed — to start-up, small, medium or large companies, Year 2000<br />
(for respondents that provided data)<br />
COMMERCIAL ACTIVIT Y<br />
Total Licences<br />
Executed<br />
Start-up<br />
Companies<br />
Percent <strong>of</strong><br />
Total<br />
Small<br />
Companies<br />
Percent <strong>of</strong><br />
Total<br />
Medium<br />
Companies<br />
Percent <strong>of</strong><br />
Total<br />
Large<br />
Companies<br />
Percent <strong>of</strong><br />
Total<br />
Universities 204 35 17 48 24 22 11 99 49<br />
Medical <strong>Research</strong> Institutes 15 6 40 1 7 5 33 3 20<br />
CSIRO 117 18 15 14 12 14 12 71 61<br />
Total 336 59 18 63 19 41 12 173 51<br />
A significant proportion <strong>of</strong> licensing activity is focused on small companies, with 47% <strong>of</strong> medical<br />
research institute licences, 41% <strong>of</strong> university licences and 27% <strong>of</strong> CSIRO licences executed to start-up or<br />
small companies.<br />
Of the 417 licences executed by universities, medical research institutes and CSIRO in<br />
Year 2000, 335 (80%) were reported as either exclusive or non-exclusive and as being<br />
executed to start-up, small, medium or large companies:<br />
<strong>of</strong> the licences executed to start-up companies, 86% were exclusive and 14% were<br />
non-exclusive.<br />
<strong>of</strong> the licences executed to small companies, 48% were exclusive and 52% were<br />
non-exclusive.<br />
<strong>of</strong> the licences executed to medium companies, 54% were exclusive and 46% were<br />
non-exclusive.<br />
<strong>of</strong> the licences executed to large companies, 29% were exclusive and 71% were<br />
non-exclusive.<br />
The very high proportion <strong>of</strong> exclusive licences executed to start-up companies suggests that the ability<br />
to grant exclusive licences is important to company start-up activity, an important contribution to the<br />
overall economic impact <strong>of</strong> licensing by universities, medical research institutes and CSIRO.<br />
B) INCOME PATTERNS<br />
The survey sought information from institutions about the number <strong>of</strong> licences that yielded<br />
income in Year 2000 and the amount <strong>of</strong> income they received from these licences in that<br />
year, in the form <strong>of</strong> running royalties, cashed-in equity and all other types <strong>of</strong> income.<br />
Income from licences<br />
The 491 licences that were executed by universities, medical research institutes and CSIRO and which<br />
yielded income in Year 2000, yielded gross income amounting to $103.6 million and adjusted gross<br />
income 7 amounting to $99.4 million in Year 2000.<br />
7<br />
Adjusted gross income from licences is gross income from licences minus licence income paid to other<br />
institutions. The subtraction <strong>of</strong> licence income paid to other institutions from gross income from licences<br />
removes a possible double count in the licence income data that may occur from the reporting <strong>of</strong> the same<br />
income by more than one institution.<br />
31